Chilton Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Chilton Capital Management's RGEN Position: Q2 2026 in Review
Chilton Capital Management sold out of Repligen (RGEN) in Q2 2026, closing a stake of 53 shares — an estimated $6.25K sold.
Chilton Capital Management first reported a position in RGEN in Q2 2024 and held it in 3 quarters. The position peaked at $21.3K in Q3 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Chilton Capital Management reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
- Chilton Capital Management sold 53 Repligen shares in Q2 2026, an estimated $6.25K.
- Chilton Capital Management first reported a position in Repligen in Q2 2024 and held it in 3 quarters.
- Chilton Capital Management's Repligen position peaked at $21.3K in Q3 2024.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.